Milestone Scientific (NYSE:MLSS) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS) in a report released on Tuesday morning. The firm issued a hold rating on the stock.

Separately, Benchmark reaffirmed a “speculative buy” rating and issued a $1.25 price objective on shares of Milestone Scientific in a report on Wednesday, November 20th.

Milestone Scientific Trading Up 26.4 %

Shares of MLSS opened at $1.00 on Tuesday. Milestone Scientific has a 12 month low of $0.52 and a 12 month high of $1.10. The firm’s 50 day moving average is $0.83 and its 200-day moving average is $0.84. The stock has a market capitalization of $77.89 million, a PE ratio of -14.29 and a beta of 1.08.

Insider Buying and Selling at Milestone Scientific

In other Milestone Scientific news, Director Leonard Osser sold 107,984 shares of the firm’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total value of $100,425.12. Following the sale, the director now owns 4,606,882 shares of the company’s stock, valued at approximately $4,284,400.26. This trade represents a 2.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders have sold a total of 109,193 shares of company stock valued at $101,634 in the last ninety days. 24.75% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Milestone Scientific

A number of institutional investors have recently modified their holdings of the business. Y Intercept Hong Kong Ltd acquired a new position in Milestone Scientific during the third quarter worth about $48,000. Geode Capital Management LLC increased its position in Milestone Scientific by 6.4% during the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after purchasing an additional 31,572 shares in the last quarter. Finally, World Investment Advisors LLC bought a new position in Milestone Scientific in the 3rd quarter valued at approximately $91,000. Institutional investors and hedge funds own 5.79% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.